日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study

蔗糖铁氧氢氧化物与碳酸司维拉姆治疗中国高磷血症透析患者的疗效和安全性比较：一项随机、开放标签、多中心、为期12周的III期研究

期刊:Nephron
影响因子:1.8
doi:10.1159/000531869
Liu, Jun; Zuo, Li; Walpen, Sebastian; Bernard, Laurence; Marty, Matthieu; Enoiu, Milica
发表日期：2024
文献求助 收藏

Current Practices in CKD-Associated Pruritus: International Nephrologist Survey

慢性肾脏病相关瘙痒症的当前诊疗实践：国际肾脏病医师调查

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2023.04.003
Burton, James O; Walpen, Sebastian; Danel, Sandrine; Schröppel, Bernd
发表日期：2023
文献求助 收藏

Utility of a Single Itch-Related Question and the Skindex-10 Questionnaire for Assessing Pruritus and Predicting Health-Related Quality of Life in Patients Receiving Hemodialysis

单个瘙痒相关问题和 Skindex-10 问卷在评估血液透析患者瘙痒症状和预测其健康相关生活质量方面的效用

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2022.100476
Lopes, Marcelo Barreto; Karaboyas, Angelo; Sukul, Nidhi; Tsuruya, Kazuhiko; Al Salmi, Issa; Asgari, Elham; Alyousef, Anas; Schaufler, Thilo; Walpen, Sebastian; Menzaghi, Frederique; Pisoni, Ronald
发表日期：2022
文献求助 收藏

Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study

地非利法林治疗中重度瘙痒血液透析患者的安全性和有效性：一项开放标签、多中心研究

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2022.100542
Weiner, Daniel E; Vervloet, Marc G; Walpen, Sebastian; Schaufler, Thilo; Munera, Catherine; Menzaghi, Frédérique; Wen, Warren; Bhaduri, Sarbani; Germain, Michael J
发表日期：2022
文献求助 收藏

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

蔗糖铁氧氢氧化物治疗透析患者高磷血症的真实世界安全性和有效性：一项前瞻性观察研究

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfaa211
Vervloet, Marc G; Boletis, Ioannis N; de Francisco, Angel L M; Kalra, Philip A; Ketteler, Markus; Messa, Piergiorgio; Stauss-Grabo, Manuela; Derlet, Anja; Walpen, Sebastian; Perrin, Amandine; Ficociello, Linda H; Rottembourg, Jacques; Wanner, Christoph; Cannata-Andía, Jorge B; Fouque, Denis
发表日期：2021
文献求助 收藏

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study

欧洲血液透析患者对磷酸盐结合剂的满意度与血清磷水平相关：透析结果和实践模式研究

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfab098
McCullough, Keith; Port, Friedrich K; de Sequera, Patricia; Rayner, Hugh; Pecoits-Filho, Roberto; Walpen, Sebastian; Evenepoel, Pieter; Pisoni, Ronald L
发表日期：2021
文献求助 收藏

Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure

蔗糖铁氧氢氧化物在慢性肾衰竭大鼠模型中的肾脏保护作用

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaa080
Neven, Ellen; Corremans, Raphaëlle; Vervaet, Benjamin A; Funk, Felix; Walpen, Sebastian; Behets, Geert J; D'Haese, Patrick C; Verhulst, Anja
Rat
发表日期：2020
文献求助 收藏

Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS

采用曲线下面积法评估长期磷控制对血液透析患者心血管死亡率的影响：来自DOPPS研究的结果

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaa054
Lopes, Marcelo Barreto; Karaboyas, Angelo; Bieber, Brian; Pisoni, Ronald L; Walpen, Sebastian; Fukagawa, Masafumi; Christensson, Anders; Evenepoel, Pieter; Pegoraro, Marisa; Robinson, Bruce M; Pecoits-Filho, Roberto
发表日期：2020
文献求助 收藏

The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

蔗糖铁氧氢氧化物在欧洲血液透析患者中的实际疗效：一项为期1年的回顾性数据库分析

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-020-02188-8
Ramos, Rosa; Chazot, Charles; Ferreira, Anibal; Di Benedetto, Attilio; Gurevich, Konstantin; Feuersenger, Astrid; Wolf, Melanie; Arens, Hans-Jürgen; Walpen, Sebastian; Stuard, Stefano
发表日期：2020
文献求助 收藏

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study

使用蔗糖铁氧氢氧化物或碳酸司维拉姆治疗后血清磷水平得到控制的患者的特征：一项3期研究的事后分析

期刊:Nephron
影响因子:1.8
doi:10.1159/000507258
Covic, Adrian C; Sprague, Stuart M; Rastogi, Anjay; Ketteler, Markus; Walpen, Sebastian; Perrin, Amandine; Floege, Jürgen
发表日期：2020
文献求助 收藏